NL-OMON36360已完成3 期
Topical Vitamin D3, Diclofenac or a combination of both to treat Basal Cell Carcinoma - Topical treatment basal cell carcinoma
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 128
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Minimum age 18 years
- •Primary basal cell carcinoma > 4 mm, histologically confirmed
- •(Micro) nodular or superficial histological subtype
- •Comorbidities may not interfere with study treatment
- •Capable to understand instructions
排除标准
- •Age under 18 years
- •Tumors located at the H-zone of the face
- •Deficient histological conformation
- •Proven or suspected malignancy of other organs
- •Not capable of comprehending instructions
- •Incompetent
- •Use of oral NSAIDs during the trial period or within 30 days before starting therapy
- •Use of oral vitamin D (containing) supplements during the trial period or within 30 days before starting therapy
研究者
相似试验
进行中（未招募）
不适用
Topical Diclofenac and Vitamin D3 to treat Basal Cell Carcinoma - VitaDiBasal Cell CarcinomaEUCTR2010-022410-11-NLMUMC64
尚未招募
2 期
Investigating the impact of topical vitamin D on anogenital wartsIRCT20230124057201N4Tehran University of Medical Sciences30
已完成
3 期
Efficacy and Safety of Topical Diclofenac Combined With Oral Diclofenac in the Treatment of Knee OsteoarthritisOsteoarthritis, KneeNCT00108992Nuvo Research Inc.750
已完成
1 期
Efficacy of vitamin D supplement and topical benzoyl peroxide in mild to moderate acneMild to moderate acneVitamin D, acne vulgarisTCTR20210616002Chulabhorn Internation College of Medicine44
尚未招募
3 期
Effectiveness of Diclofenac in the form of transdermal patch and oral tablet after tooth extractioCTRI/2021/01/030229Dr Ahana Mol U K